key: cord-0792044-ip2f80fo
authors: Serrazina, Filipa; Pinho, André Sobral; Cabral, Gonçalo; Salavisa, Manuel; Correia, Ana Sofia
title: Willingness to be vaccinated against COVID-19: an exploratory online survey in a Portuguese cohort of multiple sclerosis patients
date: 2021-03-05
journal: Mult Scler Relat Disord
DOI: 10.1016/j.msard.2021.102880
sha: 30158fd8cc5a6c662cd3905cf36f34a6db942e52
doc_id: 792044
cord_uid: ip2f80fo

BACKGROUND: : Little is known about MS patients’ acceptability of a COVID-19 vaccine. OBJECTIVE AND METHODS: : An online survey was conducted among MS patients to study COVID-19 vaccine acceptability and its associated factors. RESULTS AND CONCLUSION: : Among 256 participants, 80.9% of the patients were either definitely or probably willing to receive a COVID-19 vaccine. Most hesitant patients would consider being vaccinated under physician recommendation. Older patients and those with comorbidities seem to be more willing to get vaccinated. Moreover, vaccine acceptability was associated with participants’ convictions and concerns about COVID-19, as well as previous vaccination practices.

The availability of COVID-19 vaccines has been heralded as key to control the COVID-19

pandemic; yet little is known about MS patients' acceptability of a COVID-19 vaccine. Common concerns may include vaccine safety and effectiveness(1), (2) , (3) .

The main objective of our study was to evaluate the willingness to get a COVID-19 vaccine among MS patients, and also to investigate possible association with demographic, clinical and psychosocial factors.

We performed an observational, cross-sectional, hospital-based, single-center study, using an online survey. A voluntary, anonymized, self-administered web-based survey was conducted from 21 st December 2020 (the day when EMA recommended first COVID-19 vaccine for authorization in the European Union) through 3 rd January 2021. Patients diagnosed with MS according to the 2017 McDonald criteria, followed at Egas Moniz Hospital (a tertiary hospital in Lisbon), were invited to answer the survey by an email with a link to the survey website, in Google Forms. Patients who are not fluent in Portuguese and those with dementia were excluded.

The questionnaire was designed based on scientific literature (1,2). We assessed participants' vaccine acceptability by asking how willing they would be to get a COVID-19 vaccine; response options included "definitely willing", "probably willing", "probably not willing" and "definitely not willing".

Statistical analysis was performed using SPSS (V.25.0; IBM Corporation®). Baseline analysis of our population was performed using descriptive statistics. In order to study the factors associated with the willingness to get a COVID-19 vaccine, patients' answers were dichotomized regarding vaccine acceptability into "willing" (definitely or probably willing) or "not willing" (definitely not willing or probably not willing). Continuous data were evaluated using T or Mann-Whitney U tests and Chi-square test was performed to compare categorical data between groups. P values < 0.05 were considered statistically significant. Older patients (p=0.016) and those with comorbidities (p=0.047) seem to be more willing to get vaccinated. Also, men (p= 0.062) and patients who are unable to walk independently (p= 0.083) were more likely to be interested in getting a COVID-19 vaccine but both results did not reach statistical significance. Patients who wanted to be vaccinated had a higher desire of acquiring self-protection from the vaccine (p<0.001), as well as protection of family (p<0.001) and community (p<0.001). Also, vaccine acceptability was associated with COVID-19 information-seeking behavior (p=0.001) and the belief that population COVID-19 vaccination will bring life to normal (p=0.001). On the other hand, patients who were reluctant to receive a COVID-19

vaccine were less concerned about COVID-19 disease (p=0.004) and they reported that COVID-19 pandemic has had less impact in their lives (p=0.032) when compared with the group of patients who wanted to be vaccinated. Hesitant patients also manifested more concerns about potential side effects (p<0.001) and the vaccine safety-profile in patients with MS (p=<0.001) or under their DMT (p=0.020). Patients up to date on their vaccination schedule (according to the Portuguese National Vaccination Programme) reported more willingness to get a COVID-19 vaccine (p<0.001) while patients with previous history of vaccine refusal were less inclined to get a COVID-19 vaccine (though it did not reach statistical significance; p= 0.06). A previous diagnosis of COVID-19 disease (found in 6 participants; 2.3%) did not seem to influence the intent to receive a COVID-19 vaccine (p=0.876). (Table 1 

To our knowledge, this is the first European study reporting the acceptability of COVID-19 vaccines in a MS population. The high response rate obtained in this survey may reflect the significant interest in this subject among MS patients.

We found that approximately 81% of MS patients were willing to receive a COVID-19 vaccine. This is in line with the findings of a European study conducted in the general population in April 2020 reporting 73.9% vaccine acceptability (2) . Moreover, a US study conducted in the same period among MS patients found that 66% of the participants were willing to get a future COVID-19 vaccine whereas 15.4% of the sample was unwilling (4). Interestingly, many of our patients would prefer to postpone vaccination, probably due to uncertainty about efficacy and risks of COVID-19 vaccines. In fact, most participants reported concerns regarding the safety of COVID-19 vaccines suggesting that MS patients might be particularly apprehensive about adverse effects. Despite that, most hesitant patients would consider being vaccinated under recommendation of their physician. Interestingly, the US study found that the two COVID-19 information sources most highly trusted, and also highly associated with COVID-19 vaccine willingness among MS patients, were healthcare providers and the National MS Society (4).

These findings emphasize the primary role of physicians in promoting the uptake of COVID-19 vaccines.

Our survey revealed that older patients and participants with comorbidities seem to be more willing to get vaccinated. The acceptability of COVID-19 vaccines among older, disabled MS patients with comorbidities is of utmost relevance given their high risk for severe COVID-19 disease (5) . There was also a trend towards a higher vaccine acceptability among males and more disabled patients. Furthermore, our data suggest that participants' convictions and concerns about COVID-19, as well as previous vaccination practices, are linked to willingness to get vaccinated. Some of these findings are in agreement with previous studies conducted in the general population (1),(2),(6), (7) . On the other hand, a US study found that greater willingness to receive the vaccine among MS patients was associated with having a higher level of education and a higher perception of risk of catching COVID-19 (4).

As far as we know this is the first study evaluating the acceptability of COVID-19 vaccines among MS patients that was conducted after EU's first COVID-19 vaccine approval. Nevertheless, the design of the current study is subject to limitations. It was conducted with a convenience sample from a single-center with a relatively small population size. In addition, all tests should be interpreted as part of exploratory data analysis.

We found that a large majority of MS patients are likely to accept COVID-19 vaccination. Still, 19,1% of the participants revealed vaccine hesitancy and, in those cases, strong healthcare provider recommendations will be critical to promoting vaccine uptake.

This study protocol was approved by the Institutional Ethics Committee. All participants consented to the use of recorded surveys for scientific purposes.

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

This study received no funding.

Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated?

Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19

Parents' and guardians' views on the acceptability of a future COVID-19 vaccine: A multi-methods study in England

Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States

Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis

Willingness to get the COVID-19 vaccine with and without emergency use authorization

Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic

Figure 1 -Willingness to be vaccinated against COVID-19 among MS patients

Figure 1. Willingness to be vaccinated against COVID-19 among MS patients. 80.9% of the patients were either definitely or probably willing to receive a COVID-19 vaccine